Showing results (21-30 of 103) with videos related to
Sort By:
Pageof 11
Nature Biotechnology|August 4, 2015
Mammalian synthetic circuits with RNA binding proteins for RNA-only deliveryLiliana Wroblewska, Tasuku Kitada, Kei Endo, et al.Hepatology International|July 15, 2026
Prognostic performance of Asian Working Group for Sarcopenia 2019 and 2025 sarcopenia definitions in cirrhosisKei Endo, Keisuke Kakisaka, Tokio Sasaki, et al.Journal of Gastroenterology and Hepatology|January 25, 2020
Sustained virologic response by direct-acting antivirals suppresses skeletal muscle loss in hepatitis C virus infectionKei Endo, Takuro Sato, Akiko Suzuki, et al.ACS Synthetic Biology|May 9, 2013
Feedback control of protein expression in mammalian cells by tunable synthetic translational inhibitionJames A Stapleton, Kei Endo, Yoshihiko Fujita, et al.Clinics and Practice|April 26, 2014
Incidence of dehydration encephalopathy among patients with disturbed consciousness at a hospital emergency unitEmina Ogawa, Ryuji Sakakibara, Kei Endo, et al.Diabetes Research and Clinical Practice|May 23, 2006
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertensionAtsuhito Saiki, Masahiro Ohira, Kei Endo, et al.Journal of Atherosclerosis and Thrombosis|May 15, 2010
Pioglitazone decreases plasma angiotensin II concentration in type 2 diabetesAtsuhito Saiki, Masahiro Ohira, Kei Endo, et al.Internal Medicine (Tokyo, Japan)|December 28, 2017
Hepatic Angiomyolipoma Staining in the Post-vascular Phase of Contrast-enhanced Ultrasound Due to the Presence of MacrophagesKei Endo, Hidekatsu Kuroda, Keisuke Kakisaka, et al.Journal of Atherosclerosis and Thrombosis|January 13, 2005
Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemiaKei Endo, Yoh Miyashita, Atsuhito Saiki, et al.Metabolism: Clinical and Experimental|April 21, 2009
Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitusAtsuhito Saiki, Masahiro Ohira, Kei Endo, et al.Pageof 11